NO772493L - 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl)-og 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrol-1-karboksylsyrederivater og fremgangsm}te til deres fremstilling. - Google Patents

5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl)-og 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrol-1-karboksylsyrederivater og fremgangsm}te til deres fremstilling.

Info

Publication number
NO772493L
NO772493L NO772493A NO772493A NO772493L NO 772493 L NO772493 L NO 772493L NO 772493 A NO772493 A NO 772493A NO 772493 A NO772493 A NO 772493A NO 772493 L NO772493 L NO 772493L
Authority
NO
Norway
Prior art keywords
thenoyl
furoyl
pyrrol
pyrrolo
dihydro
Prior art date
Application number
NO772493A
Other languages
English (en)
Other versions
NO147563B (no
NO147563C (no
Inventor
Joseph M Muchowski
Arthur F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/771,283 external-priority patent/US4087539A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO772493L publication Critical patent/NO772493L/no
Publication of NO147563B publication Critical patent/NO147563B/no
Publication of NO147563C publication Critical patent/NO147563C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO772493A 1976-07-14 1977-07-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 5-(2-furoyl-, 5-(2-tenoyl)-, 5-(3-furoyl)- og 5-(3-tenoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater NO147563C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70485776A 1976-07-14 1976-07-14
US05/771,283 US4087539A (en) 1976-07-14 1977-02-23 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof

Publications (3)

Publication Number Publication Date
NO772493L true NO772493L (no) 1978-01-17
NO147563B NO147563B (no) 1983-01-24
NO147563C NO147563C (no) 1983-05-18

Family

ID=27107392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772493A NO147563C (no) 1976-07-14 1977-07-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 5-(2-furoyl-, 5-(2-tenoyl)-, 5-(3-furoyl)- og 5-(3-tenoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater

Country Status (26)

Country Link
JP (1) JPS539789A (no)
AR (1) AR218631A1 (no)
AU (1) AU513385B2 (no)
CA (1) CA1100140A (no)
CH (2) CH644861A5 (no)
CS (1) CS208724B2 (no)
DE (1) DE2731662A1 (no)
DK (1) DK152652C (no)
ES (2) ES460705A1 (no)
FI (1) FI63407C (no)
FR (1) FR2361396A1 (no)
GB (1) GB1554076A (no)
GR (1) GR61607B (no)
HK (1) HK17581A (no)
IE (1) IE45302B1 (no)
IL (1) IL52492A (no)
IT (1) IT1117314B (no)
MY (1) MY8100371A (no)
NL (1) NL7707652A (no)
NO (1) NO147563C (no)
NZ (1) NZ184611A (no)
PL (1) PL111408B1 (no)
PT (1) PT66779B (no)
SE (1) SE434644B (no)
SU (2) SU664566A3 (no)
YU (2) YU43157B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
JPS5910589A (ja) * 1982-06-10 1984-01-20 メルク　エンド　カムパニー　インコーポレーテツド 抗炎症剤および鎮痛剤として新規な５−（ピロ−ル−２−オイル）−１，２−ジヒドロ−３Ｈ−ピロロ〔１，２−ａ〕ピロ−ル誘導体
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
HU198927B (en) * 1987-01-14 1989-12-28 Richter Gedeon Vegyeszet Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds

Also Published As

Publication number Publication date
CS208724B2 (en) 1981-09-15
MY8100371A (en) 1981-12-31
IL52492A (en) 1981-06-29
AR218631A1 (es) 1980-06-30
JPS539789A (en) 1978-01-28
SE7708142L (sv) 1978-01-15
YU43157B (en) 1989-04-30
CH651045A5 (en) 1985-08-30
FI63407C (fi) 1983-06-10
NL7707652A (nl) 1978-01-17
DK152652C (da) 1988-09-12
YU43156B (en) 1989-04-30
GR61607B (en) 1978-12-02
GB1554076A (en) 1979-10-17
AU513385B2 (en) 1980-11-27
DE2731662A1 (de) 1978-01-19
IE45302B1 (en) 1982-07-28
DK307677A (da) 1978-01-15
HK17581A (en) 1981-05-08
SE434644B (sv) 1984-08-06
NO147563B (no) 1983-01-24
AU2697677A (en) 1979-01-18
ES470213A1 (es) 1979-09-16
JPS6254110B2 (no) 1987-11-13
PL111408B1 (en) 1980-08-30
FR2361396B1 (no) 1981-11-27
PT66779B (fr) 1978-12-18
DK152652B (da) 1988-04-05
IL52492A0 (en) 1977-10-31
IE45302L (en) 1978-01-14
NZ184611A (en) 1979-03-28
SU793400A3 (ru) 1980-12-30
DE2731662C2 (no) 1989-11-09
YU47583A (en) 1984-06-30
FI772154A (no) 1978-01-15
FI63407B (fi) 1983-02-28
CH644861A5 (en) 1984-08-31
SU664566A3 (ru) 1979-05-25
PL199602A1 (pl) 1979-01-29
ES460705A1 (es) 1979-10-01
PT66779A (fr) 1977-08-01
CA1100140A (en) 1981-04-28
YU47683A (en) 1984-04-30
NO147563C (no) 1983-05-18
IT1117314B (it) 1986-02-17
FR2361396A1 (fr) 1978-03-10

Similar Documents

Publication Publication Date Title
ZA774239B (en) 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl)-and 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives and process for the production thereof
BE867295A (fr) 3-(1h-tetrazol-5-yl)-4h-pyrido (1,2-a) pyrimidine-4-ones
NL7803378A (nl) 5-(2-pyrroyl)-1.2-dihydro-3h-pyrrolo1.2-apyrrool-1- carbonzuurderivaten en werkwijzen ter bereiding ervan.
IT7926051A0 (it) 5-(4-piridil)-6-(4-fluorofenil)-2,3-diidroimidazo (2,1-b) tiazolo eprocedimento per la sua preparazione.
DE68920219D1 (de) Temperaturkompensierte bipolare Schaltungen.
NO772494L (no) 5-aroyl-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater og fremgangsm}te til deres fremstilling
NO880187L (no) Superledende forbindelser av den k2if4strukturelle typen med hoeyovergangstemperatur, og fremgangsmaate for deresfremstilling.
NO772493L (no) 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl)-og 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrol-1-karboksylsyrederivater og fremgangsm}te til deres fremstilling.
FI893877A0 (fi) Platina (iv) diaminkomplex, foerfarande foer framstaellning av denna foerening, preparat med antitumoer verkan, vilket innehaoller aotminstone en platinafoerening och formade preparat med antitumoer verkan.
MX5340E (es) Procedimiento para preparar derivados de hexahidro 1,2,3,3a.4,5-oxo-6-6h-indolo(3,2,1-de)naftiridina
ATE8256T1 (de) Phenyliminomethyl-3-pyridin-derivate, ihre herstellung und verwendung.
DE3884576T2 (de) Furyl-, Phenylen- und Thienyl-Leukotrien-B4-Analoge.
DK479480A (da) (dl) 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl)-og 5-(3-thenoyl)-1,2-dihydro-3h-pyrrol-(1,2-a)-pyrrol-1-carboxylsyrer estere og salte
NL190573C (nl) Farmaceutisch preparaat met diuretische, antihypertensieve en cardiale werking, alsmede 2,4,7-triamino-6-fenylpteridineverbindingen.
NL190704C (nl) 3-Amino-17a-aza-D-homoandrostaanderivaten, werkwijze voor het bereiden daarvan, alsmede geneesmiddelen op basis van deze derivaten.
IT1208046B (it) Derivati 3-(idrossimetil)isochinolinici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
NO147244C (no) Fremgangsmaate til fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin
NO882771L (no) Aminopropanolderivater av 3-(3-hydroksyfenyl)-1-propanonforbindelser, samt fremgangsmaate for fremstilling derav.
ATE11415T1 (de) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidi - 4-on-derivate.
NO763195L (no) 3-karbalkoksyamino-1h-2,1,4-benzotiadiazinderivater og fremgangsm}te til deres fremstilling.
ATE86614T1 (de) Pyridinium-derivate, ihre herstellung und verwendung.
ATE10191T1 (de) 1-sulfo-2-azetidinon-derivate, ihre herstellung und pharmazeutische zusammensetzungen.
FI801306A (fi) Nya 4-amino-6,7-di(laegrealkoxi)-2-piperazinokinazolinderivat
IT7822055A0 (it) Preparazione e loro impiego. pigmenti isoindolinici, procedimento per la loro
NO890328D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.